Cargando…
Thymoquinone Protects against Hyperlipidemia-Induced Cardiac Damage in Low-Density Lipoprotein Receptor-Deficient (LDL-R(−/−)) Mice via Its Anti-inflammatory and Antipyroptotic Effects
Hyperlipidemia is a risk factor for cardiac damage and cardiovascular disease. Increasing evidence has shown that dyslipidemia-related cardiac damage is associated with lipid accumulation, oxidative stress, and inflammation. Thymoquinone (TQ) is the major constituent of Nigella sativa, commonly know...
Autores principales: | Pei, Zuo-Wei, Guo, Ying, Zhu, Huo-Lan, Dong, Min, Zhang, Qian, Wang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644313/ https://www.ncbi.nlm.nih.gov/pubmed/33178827 http://dx.doi.org/10.1155/2020/4878704 |
Ejemplares similares
-
Effect of Thymoquinone on Renal Damage Induced by Hyperlipidemia in LDL Receptor-Deficient (LDL-R(−)/(−)) Mice
por: Li, Wanjing, et al.
Publicado: (2022) -
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R(−/−)mice
por: Wang, Fei, et al.
Publicado: (2023) -
Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice
por: Xu, Jingyi, et al.
Publicado: (2018) -
Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice
por: Zhang, Xiaoqing, et al.
Publicado: (2018) -
Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins
por: Fang, William H., et al.
Publicado: (2023)